|
AU5790598A
(en)
*
|
1996-12-02 |
1998-06-29 |
Georgetown University |
Tropane derivatives and method for their synthesis
|
|
JP2002518331A
(ja)
|
1998-06-19 |
2002-06-25 |
イーライ・リリー・アンド・カンパニー |
セロトニン再取り込みの阻害
|
|
US6218383B1
(en)
*
|
1998-08-07 |
2001-04-17 |
Targacept, Inc. |
Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
|
|
EP1382605A3
(en)
*
|
1998-11-27 |
2004-09-15 |
Neurosearch A/S |
8-azabicyclo(3.2.1)oct-2-ene derivatives and their use as nAChR ligands
|
|
US6432975B1
(en)
*
|
1998-12-11 |
2002-08-13 |
Targacept, Inc. |
Pharmaceutical compositions and methods for use
|
|
US6953855B2
(en)
|
1998-12-11 |
2005-10-11 |
Targacept, Inc. |
3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
|
|
DE60007841T2
(de)
|
1999-01-28 |
2004-07-08 |
Neurosearch A/S |
Neue azabicyclo derivate und ihre verwendung
|
|
DE60006213T2
(de)
*
|
1999-01-29 |
2004-07-29 |
Abbott Laboratories, Abbott Park |
Diazabicyloderivate als nikotin-acetylcholin-rezeptorliganden
|
|
US7265115B2
(en)
|
1999-01-29 |
2007-09-04 |
Abbott Laboratories |
Diazabicyclic CNS active agents
|
|
CA2365258A1
(en)
*
|
1999-05-04 |
2000-11-09 |
Neurosearch A/S |
Heteroaryl diazabicycloalkanes, their preparation and use
|
|
US6890935B2
(en)
|
1999-11-01 |
2005-05-10 |
Targacept, Inc. |
Pharmaceutical compositions and methods for use
|
|
MY137020A
(en)
*
|
2000-04-27 |
2008-12-31 |
Abbott Lab |
Diazabicyclic central nervous system active agents
|
|
CN1185233C
(zh)
*
|
2000-07-04 |
2005-01-19 |
神经研究公司 |
芳基和杂芳基－二氮杂双环烷烃,其制备和用途
|
|
DE60122015T2
(de)
*
|
2000-10-13 |
2006-11-23 |
Neurosearch A/S |
Behandlung affektiver störungen durch kombinierte wirkung eines nikotinischen rezeptoragonisten und einer monoaminergischen substanz
|
|
US6911543B2
(en)
*
|
2001-10-02 |
2005-06-28 |
Pfizer Inc. |
Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
|
|
DE10164139A1
(de)
|
2001-12-27 |
2003-07-10 |
Bayer Ag |
2-Heteroarylcarbonsäureamide
|
|
JP2005523288A
(ja)
|
2002-02-19 |
2005-08-04 |
ファルマシア・アンド・アップジョン・カンパニー・エルエルシー |
疾病治療用の縮合した二環式−ｎ−架橋−複素環式芳香族カルボキサミド
|
|
CA2480378A1
(en)
*
|
2002-05-07 |
2003-11-20 |
Neurosearch A/S |
Novel azacyclic ethynyl derivatives
|
|
GB2398636A
(en)
*
|
2003-02-21 |
2004-08-25 |
Ipsen Ltd |
Method for determining the quantity of pre-synaptic neuromuscular blocking substance contained in a sample
|
|
EP1601664B1
(en)
*
|
2003-02-28 |
2008-04-30 |
Schering Corporation |
Biaryltetrahydroisoquinoline piperidines as selective mch receptor antagonists for the treatment of obesity and related disorders
|
|
AU2004220327B2
(en)
|
2003-03-12 |
2010-06-24 |
Pfizer Products Inc. |
Pyridyloxymethyl and benzisoxazole azabicyclic derivatives
|
|
CA2580329C
(en)
|
2004-09-13 |
2015-01-06 |
Chrono Therapeutics Inc. |
Biosynchronous transdermal drug delivery
|
|
US20060173037A1
(en)
*
|
2005-01-10 |
2006-08-03 |
Nathalie Schlienger |
Aminophenyl derivatives as selective androgen receptor modulators
|
|
ATE495178T1
(de)
|
2005-02-16 |
2011-01-15 |
Neurosearch As |
Diazabicyclische arylderivate und ihre verwendung als chinolinergische liganden an nikotin- acetylcholin-rezeptoren
|
|
DE102005007859A1
(de)
*
|
2005-02-21 |
2006-08-24 |
Lts Lohmann Therapie-Systeme Ag |
Vefahren für eine medikamentöse Kombinations-Behandlung, sowie hierfür geeignete Arzneimittel-Kombinationen
|
|
WO2006108790A1
(en)
*
|
2005-04-08 |
2006-10-19 |
Neurosearch A/S |
(+) - and (-) -8-alkyl-3-(trifluoralkylsulfonyloxy)-8-azabicycl (3.2.1.)oct-2-ene
|
|
FR2889701B1
(fr)
|
2005-08-12 |
2007-10-05 |
Sanofi Aventis Sa |
Derives de 5-pyridinyl-1-azabicyclo[3.2.1]octane, leur preparation en therapeutique.
|
|
EP1963323B1
(en)
|
2005-12-06 |
2010-07-14 |
Neurosearch A/S |
Novel diazabicyclic aryl derivatives and their medical use
|
|
US20070134169A1
(en)
*
|
2005-12-11 |
2007-06-14 |
Rabinoff Michael D |
Methods for smoking cessation or alcohol cessation or other addiction cessation
|
|
AU2007213670A1
(en)
|
2006-02-10 |
2007-08-16 |
Neurosearch A/S |
3,9-diazabicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
|
|
US7700596B2
(en)
|
2006-02-10 |
2010-04-20 |
Neurosearch A/S |
3,9-diazabicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
|
|
EP1987031A1
(en)
|
2006-02-10 |
2008-11-05 |
NeuroSearch A/S |
3-heteroaryl- 3,9-diazabicyclo[3.3.1]nonane derivatives as nicotinic acetylcholine receptor agonists
|
|
US20090247570A1
(en)
*
|
2006-06-12 |
2009-10-01 |
Pfizer Inc |
Pharmaceuticals
|
|
EP1977746B8
(en)
|
2007-04-02 |
2014-09-24 |
Parkinson's Institute |
Methods and compositions for reduction of side effects of therapeutic treatments
|
|
TWI415850B
(zh)
*
|
2007-07-20 |
2013-11-21 |
Theravance Inc |
製備ｍｕ類鴉片受體拮抗劑之中間物的方法
|
|
SA08290475B1
(ar)
|
2007-08-02 |
2013-06-22 |
Targacept Inc |
(2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
|
|
US8697722B2
(en)
*
|
2007-11-02 |
2014-04-15 |
Sri International |
Nicotinic acetylcholine receptor modulators
|
|
WO2010014257A2
(en)
*
|
2008-08-01 |
2010-02-04 |
Purdue Pharma L.P. |
Tetrahydropyridinyl and dihydropyrrolyl compounds and the use thereof
|
|
JP2012509354A
(ja)
*
|
2008-11-18 |
2012-04-19 |
ノイロサーチ アクティーゼルスカブ |
８−アザビシクロ［３．２．１］オクタ−２−エン誘導体及びモノアミン神経伝達物質再取込阻害剤としてのそれらの使用
|
|
SI2889033T1
(en)
|
2008-11-19 |
2018-08-31 |
Forum Pharmaceuticals Inc. |
Treatment of negative symptoms of schizophrenia with (R) -7-chloro-N- (chonylidin-3-yl) benzo (B) thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
|
|
TW201031664A
(en)
|
2009-01-26 |
2010-09-01 |
Targacept Inc |
Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
|
|
WO2010132423A1
(en)
*
|
2009-05-11 |
2010-11-18 |
Envivo Pharmaceuticals, Inc. |
Treatment of cognitive disorders with certain alpha-7 nicotinic acid receptors in combination with acetylcholinesterase inhibitors
|
|
EP2523562B1
(en)
*
|
2010-01-11 |
2019-01-02 |
Astraea Therapeutics, LLC |
Nicotinic acetylcholine receptor modulators
|
|
CN103221411B
(zh)
|
2010-05-17 |
2016-05-11 |
富瑞姆制药公司 |
(R)-7-氯-N-(奎宁环-3-基)苯并[b]噻吩-2-甲酰胺盐酸盐单水合物的晶型
|
|
AU2013259871A1
(en)
|
2012-05-08 |
2014-11-20 |
Forum Pharmaceuticals Inc. |
Methods of maintaining, treating or improving cognitive function
|
|
WO2014011768A1
(en)
*
|
2012-07-10 |
2014-01-16 |
Adispell, Inc. |
Anti-anxiety treatment
|
|
CA2974324A1
(en)
|
2015-01-28 |
2016-08-04 |
Zita S. Netzel |
Drug delivery methods and systems
|
|
US9724340B2
(en)
|
2015-07-31 |
2017-08-08 |
Attenua, Inc. |
Antitussive compositions and methods
|
|
EP3565617A1
(en)
|
2017-01-06 |
2019-11-13 |
Chrono Therapeutics Inc. |
Transdermal drug delivery devices and methods
|
|
US11596779B2
(en)
|
2018-05-29 |
2023-03-07 |
Morningside Venture Investments Limited |
Drug delivery methods and systems
|
|
CA3119992A1
(en)
|
2018-11-16 |
2020-05-22 |
Morningside Venture Investments Limited |
Thermally regulated transdermal drug delivery system
|
|
KR102272452B1
(ko)
|
2020-12-11 |
2021-07-05 |
(주)예광솔라 |
스파이럴 파일 공법 및 이에 적용되는 스파이럴 파일
|
|
KR200497569Y1
(ko)
|
2021-02-18 |
2023-12-21 |
주식회사 알파인랩 |
지주 기초용 스크루 파일
|